Loading company…
Torigen Pharmaceuticals develops personalized veterinary cancer vaccines made from a pet's own deactivated tumor cells.
Based in Connecticut, US, and founded in 2013, Torigen is a veterinary pharmaceutical company led by founder and CEO Ashley Kalinauskas as of May 2024. Its experimental autologous prescription product is regulated by the USDA Center for Veterinary Biologics and can be used alone or alongside chemotherapy and radiation. As of May 2024, more than 1,200 companion animals had been treated with its products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in